Parkinson’s disease — a multifactorial neurodegenerative disorder
The pathogenesis of idiopathic Parkinson’s disease (PD) is not known, but is thought to be multifactorial, deriving from environmental factors acting on genetically predisposed individuals with aging. Association studies of DNA polymorphisms are able to detect a genetic background predisposing to PD. Mechanisms as oxidative stress, xenobiotica toxicity and altered dopamine metabolism might lead to a selective cell death of most vulnerable nerve cells and represent the primary subject to be studied by DNA analysis. Furthermore, protein aggregation is likely to be a major cause for the disease. Recently it has been shown that α-synuclein is accumulated in Lewy bodies of sporadic PD and mutated in some rare families with an autosomal dominant trait of the disease (ADPD). The identification of further genes responsible for PD will subsequently lead to first insights into the pathogenesis of one of the most common neurodegenerative disorders in humans.
KeywordsTyrosine Hydroxylase Alzheimer Disease Multiple System Atrophy Lewy Body Dementia With Lewy Body
Unable to display preview. Download preview PDF.
- Frim DM, Uhler TA, Galpern WR, Beal MF, Breakefield XO, Isacson O (1994) Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat. Proc Natl Acad Sci USA 91: 5104–5108PubMedCrossRefGoogle Scholar
- Golbe LI (1993) A large kindred with PD: onset age, segregation ratios, and anticipation. Mov Disord 8: 406Google Scholar
- Jellinger KA (1993) Pathogenese und Pathophysiologie der Parkinson-Krankheit. Neuropsychiatrie 7(1): 29–37Google Scholar
- Kimpara T, Takeda A, Watanabe K, Itoyama Y, Ikawa S, Watanabe M, Arai H, Sasaki H, Higuchi S, Okita N, Takase S, Saito H, Takahashi K, Shibahara S (1997) Microsatellite polymorphism in the human heme oxygenase-1 promoter and its application in association studies with Alzheimer and Parkinson disease. Hum Genet 100: 145–147PubMedCrossRefGoogle Scholar
- Kurth JH, Eggers-Sedlet B, Liebermann A, Kurth MC (1997) Mov Disord 12(5): 835Google Scholar